PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy. oriana.nanni@irst.emr.it.\', \'Dipartimento di Scienze Mediche e Chirurgiche, Università di Bologna, Bologna, Italy.\', \'Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.\', \'Dipartimento di Statistica, Informatica, Applicazioni \'G. Parenti\' (DISIA), Università degli studi Firenze, Florence, Italy.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1186/s13063-020-04527-4
?:hasPublicationType
?:journal
  • Trials
is ?:pmid of
?:pmid
?:pmid
  • 32736597
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.291
?:rankingScore_hIndex
  • 57
is ?:relation_isRelatedTo_publication of
?:title
  • PROTECT Trial: A cluster-randomized study with hydroxychloroquine versus observational support for prevention or early-phase treatment of Coronavirus disease (COVID-19): A structured summary of a study protocol for a randomized controlled trial.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all